Swedish moist snuff and myocardial infarction among men

Epidemiology

Volumn 16, Issue 1, 2005, Pages 12-16

  Hergens, Maria Pia ^a   Ahlbom, Anders ^a,b   Andersson, Tomas ^b   Pershagen, Göran ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Stockholm Centre of Public Health   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SMOKELESS TOBACCO;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; RISK FACTORS; SMOKING; SWEDEN; TOBACCO, SMOKELESS;

EID: 13744252158     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000147108.92895.ba     Document Type: Article

References (35)

1. Hirsh JM, Hedner J, Wernstedt L, et al. Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther. 1992;52:394-401.
2. Westman EC. Does smokeless tobacco cause hypertension? South Med J. 1995;88:716-720.
3. Fant RV, Henningfield JE, Nelson RA, et al. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control. 1999;8:387-392.
4. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;17:1318-1330.
5. Benowitz NL, Porchet H, Sheiner L, et al. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther. 1988;44:23-28.
6. Holm H, Jarvis MJ, Russel MAH, et al. Nicotine intake and dependence in Swedish snuff taker. Psychopharmacology. 1992;108:507-511.
7. Djordjevic MV, Brunnemann KD, Hoffmand D. The need for regulation of carcinogenic N-Nitrosamines in oral snuff. Food Chem Toxicol. 1993;31:497-501.
8. Nilsson R. A Qualitative and quantitative risk assessment of snuff dipping. Reg Toxicol Pharmacol. 1998;28:1-16.
9. Public Health Report (Sweden). Stockholm: Epidemiology Central, National Board of Health and Welfare; 2001.
10. HB; 2002;10-20.
11. Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med. 1992;232:327-334.
12. Bolinder GM, De Faire U. Ambulatory 24-hour blood pressure monitoring in healthy, middle aged smokeless tobacco users, smokers and non-tobacco users. Long-term use of smokeless tobacco, cardiovascular mortality and risk factors. PhD thesis; Karolinska Institutet, Stockholm; 1997.
13. Shroeder KL, Chen MS. Smokeless tobacco and blood pressure. N Engl J Med. 1985;312:919.
14. Bolinder GM, Norén A, Wahren J, et al. Long-term use of smokeless tobacco and physical performance in middle aged men. Eur J Clin Invest. 1997;27:427-433.
15. Eliasson M, Lundblad D, Hagg E. Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med. 1991;230:17-22.
16. Siegel D, Benowitz NL, Ernster VL, et al. Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health. 1992;82:417-421.
17. Eliasson M, Asplund K, Evrin PE, et al. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis. 1995;113:41-53.
18. Tucker LA. Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia. Am J Public Health. 1989;79:1048-1050.
19. Bolinder GM, De Faire U, Alfredsson L. Effects on long-term smokeless tobacco use on metabolic cardiovascular risk factors and hemostatic function. Long term use of smokeless tobacco, cardiovascular mortality and risk factors. PhD thesis; Karolinska Institutet, Stockholm; 1997.
20. Bolinder GM, Norén A, De Faire A, et al. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media and thickness in healthy middle-aged men. Atherosclerosis. 1991;132:95-103.
21. Wallenfeldt K, Hulthe J, Bokemark L, et al. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med. 2001;250:492-501.
22. Bolinder G, Akfredsson L, Englund A, et al. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994;84:399-404.
23. Accort NA, Waterbor JW, Beall C, et al. Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol. 2002;156:730-737.
24. Huhtasaari F, Asplund K, Lundberg V, et al. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ. 1992;305:1252-1256.
25. Huhtasaari F, Lundberg V, Eliasson M, et al. Smokeless tobacco as a risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol. 1999;34:1784-1790.
26. Reuterwall C, Hallqvist J, Ahlbom A, et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analyses of some major risk factors in the SHEEP study. J Intern Med. 1999;246:161-174.
27. Theorell T, Tsutsumi A, Hallqvist J, et al. Decision latitude, job strain, and myocardial infarction: a study of working men in Stockholm. The SHEEP study group. Stockholm Heart Epidemiology Program. Am J Public Health. 1998;88:382-388.
28. Hallqvist J, Diderichsen F, Theorell T, et al. Is the effect of job strain on myocardial infarction risk due to interaction between high psychological demands and low decision latitude? Results from the Stockholm Heart Epidemiology Program. Soc Sci Med. 1998;46:1405-1415.
29. Ahlbom A, Olsson UA, Pershagen G. Hälsorisker med Snus Health Risks by Snuff. Position paper. Stockholm: Swedish National Board of Health and Welfare; 1997.
30. Peltonen M, Huhtasaari F, Stegmayr B, et al. Secular trends in social patterning of cardiovascular risk factor levels in Sweden. The Northern Sweden MONICA Study 1986-1994. J Intern Med. 1998;244:1-9.
31. Rodu B, Stegmayr B, Nasic S, et al. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med. 2002;252:398-404.
32. Lindström M, Isacsson S-O, The Malmö Shoulder-Neck Study Group. Smoking cessation among daily smokers, aged 45-69 years: a longitudinal study in Malmö Sweden. Addiction. 2002;97:205-215.
33. Lindström M, Isacsson S-O, The Malmö Shoulder-Neck Study Group. Long term and transitional intermittent smokers: a longitudinal study. Tob Control. 2002;11:61-67.
34. Nyberg F, Agudo A, Boffetta P, et al. A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls. Cancer Causes Control. 1998;9:173-182.
35. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. N Am Col Cardiol. 1997;29:1422-31.